Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: Association with decreased pRb phosphorylation

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4139-4145

  Albino, A P ^a   Juan, G ^a   Traganos, F ^a   Reinhart, L ^a   Connolly, J ^a   Rose, D P ^a   Darzynkiewicz, Z ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DOCOSAHEXAENOIC ACID; POLYUNSATURATED FATTY ACID; PROTEIN P27; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CATTLE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOCOSAHEXAENOIC ACIDS; FLOW CYTOMETRY; GROWTH INHIBITORS; HUMANS; MELANOMA; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033887028     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
2. Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma
3. Melanoma: Epidemiology, pathogenesis, and new modes of treatment
4. The treatment of metastatic melanoma with chemotherapy and biologics
5. Essential fatty acids, insulin resistance, and breast cancer risk
6. n-3 polyunsaturated fatty acids and cancer
7. Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer
8. Dietary fatty acids and cancer
9. Nutrition and melanoma
10. Melanoma and dietary lipids
11. Diet and melanoma: An exploratory case-control study
12. Case-control study of malignant melanoma in Washington State: Diet, alcohol, and obesity
13. Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: A retrospective review
14. Diet and risk of cutaneous malignant melanoma: A prospective study of 50,757 Norwegian men and women
15. Influence of dietary lipid upon ultraviolet light-carcinogenesis
16. Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis
17. Influence of dietary omega-6, -3 fatty acid sources on the initiation and promotion stages of photocarcinogenesis
18. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer
19. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture
20. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice
21. Effects of fatty acids and eicosannid synthesis inhibitors on the growth of two human prostate cancer cell lines
22. Effects of dietary menhaden oil and retinyl acetate on the growth of DU145 human prostatic adenocarcinoma cells transplanted into athymic nude mice
23. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice
24. The retinoblastoma protein and cell cycle control
25. Retinoblastoma protein family in cell cycle and cancer: A review
26. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis
27. Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens
28. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues
29. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication
30. Cytometry, of cyclin proteins
31. Phosphorylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation
32. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells
33. Physical interaction of the retinoblastoma protein with human D cyclins
34. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
35. Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation
36. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
37. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells
38. Cellular pathways leading to melanoma differentiation: Therapeutic implications
39. The retinoblastoma protein pathway and the restriction point
40. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas
41. Involvement of the pRb/pl6/cdk4/cyclin DI pathway in the tumorigenesis of sporadic malignant melanomas
42. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system
43. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
44. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
45. Human melanoma genetics
46. Loss of expression of the pl6/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
47. pl6-INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
48. Novel mutations in the p16CDKN2A binding region of the cyclin-dependent kinase-4 gene
49. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
50. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: Common pathway of gene regulation
51. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kipl, inhibits growth, and enhances apoptosis
52. Caloric restriction and experimental carcinogenesis
53. Dietary factors on ultraviolet carcinogenesis
54. The mechanistic rationale in support of dietary cancer prevention
55. Effects of dietary fatty acids on breast and prostate cancers: Evidence from in vitro experiments and animal studies
56. Breast cancer: Weighing the evidence for a promoting role of dietary fat
57. Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells
58. Melanoma lung metastases and cytolytic effector cells in mice fed antioxidant-balanced corn oil or fish oil diets
59. Omega-3 fatty acids as cancer chemopreventive agents
60. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
61. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
62. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro
63. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: Effects on proliferation and apoptosis